Device Trial Radar · NCT07565545
Posterior-Inferior Intra-articular Cortical Piercing Titanium Implant for Sacroiliac Joint Fusion: Evaluation of Safety and Effectiveness Outcomes
Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
120
Planned (sponsor's estimate)
Start
Dec 2026
Primary completion
Jun 2028
Study completion Dec 2029
Sponsor
- Lead sponsor
- SI-BONE, Inc.Public (SIBN)
- Sponsor type
- Industry
- First posted
- May 4, 2026
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate outcomes in patients treated with iFuse INTRA Ti for chronic SI joint pain.
Conditions
- Sacro Iliac Joint Pain
- Sacro-iliac Joints
- Sacroiliac Disorder
- Sacroiliac Joint Dysfunction
- Sacroiliac Joint Disruption
- Degenerative Sacroiliitis
Interventions
iFuse INTRA Ti Implant SystemDevice
FDA-cleared implant used for fusion of the sacroiliac joint (SIJ) for SIJ dysfunction, that is a direct result of SIJ disruption and degenerative sacroiliitis.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Composite endpoint of safety and performanceTime frame: 6 months.
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.